Emeritus

Laxamana TD, Fervenza FC, Glassock RJ, Zand L. A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA[...]

Giri K, Glassock RJ, Fervenza FC. Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab? Kidney Int Rep. 2026 Mar 4;11(4):106416. doi: 10.1016/j.ekir.2026.106416.[...]

Oliva-Damaso N, Martinez-Palma L, Oliva-Damaso E, Payan J, Glassock RJ. Discharge criteria from nephrology follow-up back to primary care in modern-era CKD: a review of[...]

Moroni G, Glassock R, Fornoni A. Memories of Claudio Ponticelli. Kidney Int. 2026 Feb 20:S0085-2538(26)00135-3. doi: 10.1016/j.kint.2026.02.002. Epub ahead of print. PMID: 41724377.

Glassock RJ. Berger disease redux. Kidney Int. 2025 Dec;108(6):999-1001. doi: 10.1016/j.kint.2025.09.021. PMID: 41271316.

Tumlin JA, Podoll A, Kopyt N, Rovin B, Lafayette R, Bomback A, Glassock R, Whitson J, Press A, Appel GB. Efficacy of Acthar gel and[...]

Gholizadeh Ghozloujeh Z, Glassock RJ, Al Jurdi A, Jhaveri KD, Heidari-Bateni G, Bajpai D, Lerma E, Wu J, Abdipour A, Norouzi S. Venous Thromboembolism Prevention[...]

Lafayette RA, Charu V, Glassock RJ. Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations. Adv Ther. 2025 Mar 27. doi: 10.1007/s12325-025-03167-x. Epub ahead[...]

Rosansky S, Glassock R. The renal function trajectory in clinical trial design: challenges and opportunities. Kidney Int. 2024 Oct;106(4):565-568. doi: 10.1016/j.kint.2024.07.023. PMID: 39304271.

Weber KD, Mower W, Krishnadasan A, Mohr NM, Montoy JC, Rodriguez RM, Giordano PA, Eyck PT, Harland KK, Wallace K, McDonald LC, Kutty PK, Hesse[...]